Fig. 4From: An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivityA tornado plot of key parameters and their impact on net monetary benefit (at £20,000 per QALY) when varied. Abbreviations: BSC, best supportive care; EM, episodic migraine; CM, chronic migraine; UK, United KingdomBack to article page